Source: Annual Congress 2013 –Studies of asthma in man
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Thorburn, C. McKenzie, C. Mackay (Melbourne, Australia). LATE-BREAKING ABSTRACT: The effect of fibre, gut microbiota and short-chain fatty acids on the development of asthma. Eur Respir J 2013; 42: Suppl. 57, 3140

Member's Comments

No comment yet.

Related content which might interest you: Interaction of dietary fatty acids with obesity induced cytokines in primary human pulmonary fibroblasts Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Fatty acid blood spectrum in patients with asthma Source: International Congress 2016 – Asthma points to ponder Year: 2016 LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 D-tryptophan is a probiotic substance influencing the gut microbiome and in vitro Th2 differentiation Source: International Congress 2016 – Airway response to infection Year: 2016 Airway inflammation is augmented by obesity and fatty acids in asthma Source: Eur Respir J 2011; 38: 594-602 Year: 2011 LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Food and fatty acid intake and atopic disease in adults Source: Eur Respir J 2004; 23: 575-582 Year: 2004 Altered airway microbiome in stable asthma Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 LATE-BREAKING ABSTRACT: T-cell membrane organization as a potential new target in asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Critical role of proton-sensing OGR1 in dendritic cells in development of asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Content of omega-3 fatty acids partially explains the asthma-protective effect of unprocessed cow’s milk Source: International Congress 2015 – Early life matters: prematurity and risk factors for asthma Year: 2015 LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 The effect of oligomeric proanthocyanidin on airway microenvironment in asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Late Breaking Abstract: Prenatal n-3, n-6, and trans fatty acids and the risk of eosinophilia and allergic sensitization in children at age 3 years Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010 LATE-BREAKING ABSTRACT: Protective effects of surfactant protein D (SP-D) treatment in 1,3-ß-glucan-modulated allergic inflammation Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015